Impact of Angiotensin I-converting Enzyme Inhibitors and Angiotensin II Type-1 Receptor Blockers on Survival of Patients with NSCLC
Crossref DOI link: https://doi.org/10.1038/srep21359
Published Online: 2016-02-17
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Miao, Lili
Chen, Wei
Zhou, Ling
Wan, Huanying
Gao, Beili
Feng, Yun
Text and Data Mining valid from 2016-02-17
Version of Record valid from 2016-02-17
Article History
Received: 29 September 2015
Accepted: 18 January 2016
First Online: 17 February 2016
Competing interests
: The authors declare no competing financial interests.